Some studies showed that estrogen treatment increases BCSC properties, including mammosphere forming efficiency and the proportion of CD44+/CD24− cells, in ER+ breast cancer cell lines and that this effect was reversed by endocrine therapy, suggesting that ER is necessary for stem cell expansion [13, 14]. The gene discussed is CD44; the disease is breast carcinoma.